Search Results - "Sperle, Ida"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014-2017 by Sperle, Ida, Lassen, Sofie Gillesberg, Schlaud, Martin, Dörre, Achim, Dudareva, Sandra, Poethko-Müller, Christina, Harder, Thomas

    Published in BMC infectious diseases (15-03-2024)
    “…Childhood vaccination against hepatitis B has been recommended in Germany since 1995. WHO defines a primary vaccination series as successful if the initial…”
    Get full text
    Journal Article
  2. 2

    The epidemiology of Hepatitis B, C and D in Germany: A scoping review by Steffen, Gyde, Sperle, Ida, Leendertz, Siv Aina, Sarma, Navina, Beermann, Sandra, Thamm, Roma, Bremer, Viviane, Zimmermann, Ruth, Dudareva, Sandra

    Published in PloS one (09-03-2020)
    “…Germany is considered to be a low prevalence country for viral Hepatitis B, C and D (HBV, HCV, HDV). However, the burden of disease can be high among…”
    Get full text
    Journal Article
  3. 3

    Hepatitis B vaccination coverage in Germany: systematic review by Steffen, Gyde, Sperle, Ida, Harder, Thomas, Sarma, Navina, Beermann, Sandra, Thamm, Roma, Bremer, Viviane, Zimmermann, Ruth, Dudareva, Sandra

    Published in BMC infectious diseases (14-08-2021)
    “…Despite being considered as a low prevalence country for hepatitis B (HBV), some populations in Germany are at higher risk of infection. In the context of the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Associations between national viral hepatitis policies/programmes and country-level socioeconomic factors: a sub-analysis of data from the 2013 WHO viral hepatitis policy report by Lazarus, Jeffrey V, Sperle, Ida, Safreed-Harmon, Kelly, Gore, Charles, Cebolla, Beatriz, Spina, Alexander

    Published in BMC public health (26-07-2017)
    “…As more countries worldwide develop national viral hepatitis strategies, it is important to ask whether context-specific factors affect their decision-making…”
    Get full text
    Journal Article
  6. 6

    Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review by Sperle, Ida, Steffen, Gyde, Leendertz, Siv Aina, Sarma, Navina, Beermann, Sandra, Thamm, Roma, Simeonova, Yanita, Cornberg, Markus, Wedemeyer, Heiner, Bremer, Viviane, Zimmermann, Ruth, Dudareva, Sandra

    Published in Frontiers in public health (28-08-2020)
    “…One of the five strategic directions in the World Health Organization global health sector strategy on viral hepatitis 2016-2021 is to generate strong…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention by Wiessing, Lucas, Ferri, Marica, Grady, Bart, Kantzanou, Maria, Sperle, Ida, Cullen, Katelyn J, Hatzakis, Angelos, Prins, Maria, Vickerman, Peter, Lazarus, Jeffrey V, Hope, Vivian D, Matheï, Catharina

    Published in PloS one (28-07-2014)
    “…People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however…”
    Get full text
    Journal Article
  12. 12

    A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region by Lazarus, Jeffrey V, Sperle, Ida, Maticic, Mojca, Wiessing, Lucas

    Published in BMC infectious diseases (2014)
    “…Fifteen million adults in the World Health Organization European Region are estimated to have active hepatitis C infection. Intravenous drug use is a major…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe by Lazarus, Jeffrey V, Sperle, Ida, Spina, Alexander, Rockstroh, Jürgen K

    Published in Croatian medical journal (01-10-2016)
    “…To investigate whether or not key populations affected by hepatitis B and hepatitis C are being tested sufficiently for these diseases throughout the European…”
    Get full text
    Journal Article Paper